Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

US supreme court temporarily extends access to mail-order abortion medication mifepristone

Louisiana had sued the FDA last fall, arguing that prescribing mifepristone interfered with state’s ban on abortion

The Guardian - US

Police raids across 90 countries seize fake and illegal medicines worth €14m

Interpol says nearly 270 people suspected of drug trafficking have been arrested and 66 criminal groups dismantled following a major international police operation spanning 90 countries.

Radio France Internationale

White House Says Trump's Drugmaker Deals Could Save U.S. Economy $529 Billion Over 10 Years

The White House said on Tuesday that agreements with major drugmakers could save the U.S. economy $529 billion over the next decade.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Supreme Court Asked to Restore Mail Access to Abortion Pill After Sweeping Appellate Ruling

Two makers of the abortion pill mifepristone asked the Supreme Court to block a federal appellate ruling that cut off mail-order access to the drug, in what legal experts are calling the most significant jolt to abortion policy since the overturning of Roe v. Wade.

Latin Times

Abortion pill maker asks US supreme court to halt ban on mail-order access

Danco Laboratories files emergency appeal after lower court blocks telemedicine providers from prescribing

The Guardian - US

Rule that lets Texans obtain out-of-state abortion pills can continue for now, Supreme Court says

The 5th U.S. Circuit Court of Appeals ruled that mifepristone must be obtained in person, a decision the country’s highest court has temporarily blocked.

The Texas Tribune

OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a new entity

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

UK Biobank has my data, but I’m not worried. I know the benefits are too great to consider pulling out

Longitudinal studies are a research jewel, shedding light on motor neurone disease, cot deaths, Alzheimer’s and more. Don’t let the security breach in China put you off joining one, says Guardian columnist Polly Toynbee

The Guardian - UK

Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales

Purdue Pharma has been sentenced to pay $5.5 billion after pleading guilty to deceiving regulators and fueling the US opioid crisis through aggressive and illegal opioid sales practices.

International Business Times

AstraZeneca to inject £300 million into UK in surprise U-turn

AstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’

The Independent UK

More private health records of UK Biobank volunteers appear on Chinese website

Patrick Vallance says government working with Chinese officials to remove postings from Alibaba after Biobank data breach last week

The Guardian - UK

AstraZeneca makes surprise U-turn with £300m pharma investment in UK

Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer

The Guardian - UK

OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves

OxyContin maker Purdue Pharma is expected to be ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller

The Independent UK

Trump Appears to Doze Off During Live Oval Office Event as Video of Him Mocking 'Sleepy Joe' Biden Resurfaces

President Trump, 79, appeared to nod off during a live Oval Office event, sparking renewed scrutiny over his health. The incident contrasts with his past criticism of Biden's on-camera drowsiness.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Trump will unveil a deal with Regeneron to lower drug prices

President Donald Trump is set to announce a deal with Regeneron to lower drug costs as part of the White House's effort to lower drug prices

The Guardian - UK

Private health records of half a million Britons offered for sale on Chinese website

Technology minister tells Commons ‘de-identified’ information from UK Biobank advertised for sale on Alibaba

The Independent UK

Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government

International Business Times

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Eli Lilly and Co Reportedly Close to $2 Billion Acquisition of Kelonia Therapeutics

Eli Lilly is reportedly nearing a $2 billion deal to acquire Kelonia Therapeutics, aiming to expand its cancer treatment portfolio with next-generation therapies.

International Business Times UK

Donald Trump's TrumpRx Falls Short? Report Finds Drug Prices Still Rising

Recent reports question the TrumpRx initiative's effectiveness in reducing US drug prices, highlighting continued price increases and disparities with the UK's NHS system.

International Business Times UK

Xanax Recall: FDA Issues Nationwide Alert for Specific Extended-Release Tablets—Check Your Prescription Now

A batch of Xanax XR is recalled due to improper dissolution, posing potential health risks. The FDA advises patients to consult their doctors for alternatives.

AAP

More women set to skip the doctor to get the pill

Many women at low risk of complications will soon be able to access the contraceptive pill without a trip to their GP, but the rollout will not be swift.

Tom’s Guide

Oxiline Scale MD Pro review

The Oxiline Scale MD Pro is a strange smart scale. Priced almost like a Withings but performing like a budget option, I’m not sure who this is for.

The Guardian - UK

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

The Independent UK

New drug ‘10 times more potent than fentanyl’ and linked to dozens of deaths in Tennessee is spreading across US

The drug belongs to an emergent subclass of synthetic opioids known as ‘orphines’ which first appeared on the recreational drug market in 2020

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Harvard Medical School

135 stories

Purdue Pharma

135 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.